According to Greenwich LifeSciences's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -A$15.18 Million a decrease over its 2022 earnings that were of -A$13.09 Million. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 (TTM) | -A$15.98 Million | 5.28% |
2023 | -A$15.18 Million | 16.01% |
2022 | -A$13.09 Million | 74.87% |
2021 | -A$7.49 Million | 146.7% |
2020 | -A$3.04 Million |